We have located links that may give you full text access.
Analysis of an improved survival rate for congenital diaphragmatic hernia.
Journal of Pediatric Surgery 2003 May
BACKGROUND/PURPOSE: Congenital diaphragmatic hernia (CDH) is a condition associated with significant mortality. This study examines the survival rate of neonates with CDH treated by a multidisciplinary team in a single pediatric hospital. Actual survival rate is compared with predicted outcome based on severity of illness.
METHODS: A consecutive series of neonates with CDH was evaluated beginning January 1, 2000. There were no excluded patients. A treatment protocol emphasizing minimal barotrauma and control of pulmonary hypertension was used. Predicted survival rate was estimated using birth weight and Apgar score at 5 minutes per the logistic regression equation published by the CDH Study Group. Actual survival rates were calculated and compared with predicted values using a one sample binomial test with significance deemed to be present at P less than.05.
RESULTS: Thirty-six of 39 (93%) neonates with CDH survived, whereas the predicted survival rate for this cohort was 68% (P <.001). Twelve of 14 (86%) neonates requiring extracorporeal membrane oxygenation (ECMO) survived, despite a predicted survival rate of 52% for this subset (P <.01). Twenty-five percent of survivors required supplemental oxygen at home.
CONCLUSIONS: Using a simple analysis, centers may now objectively compare their CDH survival rates with predicted outcomes adjusted for disease severity. This technique confirmed that a consecutive series of neonates with CDH, treated in one hospital, had a significantly higher than predicted survival rate. Thus, it may be possible to identify other centers with higher than expected survival rates and to define common therapeutic strategies associated with decreased mortality.
METHODS: A consecutive series of neonates with CDH was evaluated beginning January 1, 2000. There were no excluded patients. A treatment protocol emphasizing minimal barotrauma and control of pulmonary hypertension was used. Predicted survival rate was estimated using birth weight and Apgar score at 5 minutes per the logistic regression equation published by the CDH Study Group. Actual survival rates were calculated and compared with predicted values using a one sample binomial test with significance deemed to be present at P less than.05.
RESULTS: Thirty-six of 39 (93%) neonates with CDH survived, whereas the predicted survival rate for this cohort was 68% (P <.001). Twelve of 14 (86%) neonates requiring extracorporeal membrane oxygenation (ECMO) survived, despite a predicted survival rate of 52% for this subset (P <.01). Twenty-five percent of survivors required supplemental oxygen at home.
CONCLUSIONS: Using a simple analysis, centers may now objectively compare their CDH survival rates with predicted outcomes adjusted for disease severity. This technique confirmed that a consecutive series of neonates with CDH, treated in one hospital, had a significantly higher than predicted survival rate. Thus, it may be possible to identify other centers with higher than expected survival rates and to define common therapeutic strategies associated with decreased mortality.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app